{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:38:09Z","timestamp":1792172289710,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmoodanxdisorders.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mood &amp; Anxiety Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xjmad.2026.100168","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:40:37Z","timestamp":1768718437000},"page":"100168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Reconsidering the glutamate hypothesis of obsessive-compulsive disorder: A systematic review of proton magnetic resonance spectroscopy studies in unmedicated participants"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9802-7138","authenticated-orcid":false,"given":"Gabriella","family":"Restifo-Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-0279","authenticated-orcid":false,"given":"Jia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-1167","authenticated-orcid":false,"given":"Lawrence S","family":"Kegeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-2245","authenticated-orcid":false,"given":"Dikoma C","family":"Shungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9332-2839","authenticated-orcid":false,"given":"Helen Blair","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100168_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4088\/JCP.v67n0214","article-title":"Response versus remission in obsessive-compulsive disorder","volume":"67","author":"Simpson","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100168_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4088\/JCP.12m07789","article-title":"Treatment response, symptom remission, and wellness in obsessive-compulsive disorder","volume":"74","author":"Farris","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways","volume":"16","author":"Milad","year":"2012","journal-title":"Trends Cogn Sci"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100168_bib6","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1038\/s41380-020-01007-8","article-title":"Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder","volume":"26","author":"Shephard","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.euroneuro.2015.12.005","article-title":"Brain circuitry of compulsivity","volume":"26","author":"van den Heuvel","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100168_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.pbb.2011.08.008","article-title":"Overview of glutamatergic neurotransmission in the nervous system","volume":"100","author":"Niciu","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70029","article-title":"The glutamate\/GABA-glutamine cycle: insights, updates, and advances","volume":"169","author":"Andersen","year":"2025","journal-title":"J Neurochem"},{"issue":"124","key":"10.1016\/j.xjmad.2026.100168_bib10","article-title":"A gut feeling about GABA: focus on GABA(B) receptors","volume":"1","author":"Hyland","year":"2010","journal-title":"Front Pharmacol"},{"issue":"48","key":"10.1016\/j.xjmad.2026.100168_bib11","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100168_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100168_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0006-3223(97)00443-5","article-title":"Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder","volume":"43","author":"Rosenberg","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100168_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1600-0447.2000.102006401.x","article-title":"On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions","volume":"102","author":"Carlsson","year":"2000","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100168_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","article-title":"Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder","volume":"3","author":"Pittenger","year":"2006","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0278-5846(00)00146-9","article-title":"On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder","volume":"25","author":"Carlsson","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100168_bib19","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.xjmad.2026.100168_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0006-3223(00)01073-8","article-title":"Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development","volume":"48","author":"Rosenberg","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.xjmad.2026.100168_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1875397300802010062","article-title":"Glutamatergic synaptic dysfunction and obsessive-compulsive disorder","volume":"2","author":"Ting","year":"2008","journal-title":"Curr Chem Genom"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100168_bib22","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100168_bib23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biopsych.2012.06.023","article-title":"A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder","volume":"73","author":"Brennan","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"20","key":"10.1016\/j.xjmad.2026.100168_bib25","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.81.20.6330","article-title":"Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo","volume":"81","author":"Rothman","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xjmad.2026.100168_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.13895","article-title":"Neurometabolic dysregulation within the cortico-striatal-thalamo-cortical circuits in obsessive-compulsive disorder: a (1)H-MRS meta-analysis","author":"Zhu","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.xjmad.2026.100168_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103517","article-title":"Neurometabolite changes in response to antidepressant medication: a systematic review of","volume":"40","author":"Boucherie","year":"2023","journal-title":"Neuroimage Clin"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib28","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41380-023-01991-7","article-title":"Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis","volume":"28","author":"Merritt","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100168_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/pcn.12850","article-title":"Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment","volume":"73","author":"Parmar","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100168_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pscychresns.2015.06.001","article-title":"In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: proof of concept","volume":"233","author":"Rodriguez","year":"2015","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.xjmad.2026.100168_bib31","article-title":"Methodological standards for conducting high-quality systematic reviews","volume":"14","author":"De Cassai","year":"2025","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.xjmad.2026.100168_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"issue":"11","key":"10.1016\/j.xjmad.2026.100168_bib33","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1176\/ajp.155.11.1584","article-title":"A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects","volume":"155","author":"Bartha","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pnpbp.2011.09.007","article-title":"MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder","volume":"36","author":"O'Neill","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.xjmad.2026.100168_bib35","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/npp.2012.132","article-title":"Investigation of cortical glutamate-glutamine and \u03b3-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy","volume":"37","author":"Simpson","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pscychresns.2011.01.017","article-title":"Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment","volume":"201","author":"L\u00e1zaro","year":"2012","journal-title":"Psychiatry Res"},{"issue":"1-2","key":"10.1016\/j.xjmad.2026.100168_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pscychresns.2014.02.004","article-title":"Proton magnetic resonance spectroscopy of prefrontal white matter in psychotropic na\u00efve children and adolescents with obsessive-compulsive disorder","volume":"222","author":"Weber","year":"2014","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pscychresns.2015.01.009","article-title":"Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy","volume":"232","author":"Simpson","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.xjmad.2026.100168_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2015.03.008","article-title":"Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy","volume":"178","author":"Zhu","year":"2015","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib40","first-page":"263","article-title":"Brain gamma-aminobutyric acid (GABA) concentration of the prefrontal lobe in unmedicated patients with obsessive-compulsive disorder: a research of magnetic resonance spectroscopy","volume":"28","author":"Zhang","year":"2016","journal-title":"Shanghai Arch Psychiatry"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/neu.2016.52","article-title":"1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder","volume":"29","author":"Ljungberg","year":"2017","journal-title":"Acta Neuropsychiatr"},{"issue":"12","key":"10.1016\/j.xjmad.2026.100168_bib42","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/npp.2017.163","article-title":"Fronto-striatal glutamate in autism spectrum disorder and obsessive compulsive disorder","volume":"42","author":"Naaijen","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.xjmad.2026.100168_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pscychresns.2018.05.004","article-title":"Anterior thalamic radiation structural and metabolic changes in obsessive-compulsive disorder: a combined DTI-MRS study","volume":"277","author":"Wang","year":"2018","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0004867418806370","article-title":"The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex\/middle occipital gyrus in unmedicated obsessive-compulsive disorder: a combined fMRI and","volume":"53","author":"Chen","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12888-019-2160-1","article-title":"Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy","volume":"19","author":"Li","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"11","key":"10.1016\/j.xjmad.2026.100168_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_663_23","article-title":"Proton magnetic resonance spectroscopy-based evaluation of metabolic abnormalities in the right dorsolateral prefrontal cortex and caudate nucleus in treatment-na\u00efve patients with obsessive-compulsive disorder","volume":"65","author":"Hans","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.xjmad.2026.100168_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpsychires.2025.04.011","article-title":"Altered glutamate concentration in the subcortical nuclei and its correlation with resting-state functional connectivity in unmedicated obsessive-compulsive disorder","volume":"186","author":"Hou","year":"2025","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.xjmad.2026.100168_bib48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.chi.0000087562.01900.de","article-title":"Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy","volume":"42","author":"Benazon","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100168_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","article-title":"Harmonizing the neurobiology and treatment of obsessive-compulsive disorder","volume":"178","author":"Goodman","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100168_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mrm.1910390110","article-title":"Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS","volume":"39","author":"Pouwels","year":"1998","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100168_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/nbm.1940040205","article-title":"Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites","volume":"4","author":"Ross","year":"1991","journal-title":"NMR Biomed"},{"issue":"11","key":"10.1016\/j.xjmad.2026.100168_bib54","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100168_bib55","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41380-019-0431-3","article-title":"Lower excitatory synaptic gene expression in orbitofrontal cortex and striatum in an initial study of subjects with obsessive compulsive disorder","volume":"26","author":"Piantadosi","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100168_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajmg.b.30152","article-title":"Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder","volume":"134B","author":"Zai","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/npp.2011.300","article-title":"Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder","volume":"37","author":"Richter","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6137","key":"10.1016\/j.xjmad.2026.100168_bib58","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1232380","article-title":"Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors","volume":"340","author":"Burguiere","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.xjmad.2026.100168_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/B978-0-444-64123-6.00025-4","article-title":"Obsessive-compulsive and related disorders","volume":"175","author":"Mattina","year":"2020","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100168_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4484","article-title":"Minimum reporting standards for in vivo magnetic resonance spectroscopy (MRSinMRS): experts' consensus recommendations","volume":"34","author":"Lin","year":"2021","journal-title":"NMR Biomed"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100168_bib62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mrm.27742","article-title":"Methodological consensus on clinical proton MRS of the brain: review and recommendations","volume":"82","author":"Wilson","year":"2019","journal-title":"Magn Reson Med"},{"issue":"Pt B","key":"10.1016\/j.xjmad.2026.100168_bib63","article-title":"Deep learning-based MRI reconstruction with artificial fourier transform network (AFTNet)","volume":"192","author":"Yang","year":"2025","journal-title":"Comput Biol Med"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100168_bib64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed"},{"key":"10.1016\/j.xjmad.2026.100168_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108827","article-title":"Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data","volume":"343","author":"Oeltzschner","year":"2020","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.xjmad.2026.100168_bib66","article-title":"Q-MRS: a deep learning framework for quantitative magnetic resonance spectra analysis","author":"Wu","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.xjmad.2026.100168_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fpsyt.2018.00076","article-title":"Functional magnetic resonance spectroscopy: the \"New\" MRS for cognitive neuroscience and psychiatry research","volume":"9","author":"Stanley","year":"2018","journal-title":"Front Psychiatry"}],"container-title":["Journal of Mood &amp; Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950004426000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950004426000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:05:34Z","timestamp":1774497934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950004426000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"alternative-id":["S2950004426000039"],"URL":"https:\/\/doi.org\/10.1016\/j.xjmad.2026.100168","relation":{},"ISSN":["2950-0044"],"issn-type":[{"value":"2950-0044","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconsidering the glutamate hypothesis of obsessive-compulsive disorder: A systematic review of proton magnetic resonance spectroscopy studies in unmedicated participants","name":"articletitle","label":"Article Title"},{"value":"Journal of Mood & Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjmad.2026.100168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Anxiety and Depression Association of America.","name":"copyright","label":"Copyright"}],"article-number":"100168"}}